View the V-GAVIR 450 registration information details.
Back to drug list
ItemsDrug Registration information
ID372
No372
Brand NameV-GAVIR 450
IngredientsVALGANCICLOVIR HCL USP EQ.TO VALGANCICLOVIR 450 MG
Dosage FormFILM-COATED TABLETS
Primary PackagingALU-STRIP
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 5 X 4'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE INDUCTION AND MAINTENANCE TREATMENT OF CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME, FOR THE PREVENTION OF CMV DISEASE IN CMV-NEGATIVE PATIENTS WHO HAVE RECEIVED A SOLID ORGAN TRANSPLANT FROM A CMV-POSITIVE DONOR
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionDARK BROWN COLOURED, CAPSULE SHAPED BICONVEX, FILM COATED TABLETS
Note
License OwnerCBF PHARMA CO.,LTD
ManufacturerUNITED BIOTECH (P) LIMITED
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No06 I 4943/20
FDD Registration Date14/08/2023
Expiry Date13/08/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA